Business Description
China Biotech Services Holdings Ltd
ISIN : BMG7713H1575
Total Employee Number:
149Compare
Compare
Traded in other countries / regions
08037.Hong Kong IPO Date
2004-06-17Description
China Biotech Services Holdings Ltd is an investment holding company. It operates through five segments: Pharmaceutical Products, Medical and Health-Related Services, Immunotherapy, Insurance brokerage, BNCT, and Others. It derives prime revenue from the Medical & health-related services segment, which involves the provision of medical laboratory testing & health check services. The group has a business presence in Hong Kong & the PRC, of which key revenue is generated from Hong Kong. Immunotherapy-provision of tumor immune cell therapy & health management services. Pharmaceutical products-sale & distribution of health-related & pharmaceutical products. Insurance brokerage services. BNCT-provision of boron neutron capture therapy treatment services, & Others-provision of logistic services.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.27 | |||||
Debt-to-Equity | 2.06 | |||||
Debt-to-EBITDA | -6.35 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -1.16 | |||||
Beneish M-Score | -3.95 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -66.1 | |||||
3-Year Book Growth Rate | -31.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.34 | |||||
9-Day RSI | 54.9 | |||||
14-Day RSI | 55.64 | |||||
3-1 Month Momentum % | -20.9 | |||||
6-1 Month Momentum % | -30.26 | |||||
12-1 Month Momentum % | -29.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.23 | |||||
Quick Ratio | 0.12 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 80.39 | |||||
Days Sales Outstanding | 34.16 | |||||
Days Payable | 90.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | -20.46 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 10.51 | |||||
Operating Margin % | -102.41 | |||||
Net Margin % | -93.57 | |||||
EBITDA Margin % | -84.66 | |||||
FCF Margin % | -62.55 | |||||
OCF Margin % | -62.55 | |||||
ROE % | -29.68 | |||||
ROA % | -11.65 | |||||
ROIC % | -10.21 | |||||
3-Year ROIIC % | 5638.75 | |||||
ROC (Joel Greenblatt) % | -21.24 | |||||
ROCE % | -18 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 8.53 | |||||
PB Ratio | 3.23 | |||||
Price-to-Tangible-Book | 16 | |||||
EV-to-EBIT | -15.54 | |||||
EV-to-EBITDA | -15.54 | |||||
EV-to-Revenue | 13.16 | |||||
EV-to-FCF | -21.03 | |||||
Price-to-GF-Value | 2.37 | |||||
Price-to-Projected-FCF | 0.92 | |||||
Price-to-Median-PS-Value | 2.28 | |||||
Earnings Yield (Greenblatt) % | -6.44 | |||||
FCF Yield % | -7.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
China Biotech Services Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 73.503 | ||
| EPS (TTM) (HK$) | -0.07 | ||
| Beta | 0.2122 | ||
| 3-Year Sharpe Ratio | 0.01 | ||
| 3-Year Sortino Ratio | 0.03 | ||
| Volatility % | 76.74 | ||
| 14-Day RSI | 55.64 | ||
| 14-Day ATR (HK$) | 0.069927 | ||
| 20-Day SMA (HK$) | 0.58875 | ||
| 12-1 Month Momentum % | -29.33 | ||
| 52-Week Range (HK$) | 0.3 - 1.33 | ||
| Shares Outstanding (Mil) | 968.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
China Biotech Services Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
China Biotech Services Holdings Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| 0.5:1 Stock Split | 2016-02-23 | 0.20 (-1.96%) | ||
| 0.2:1 Stock Split | 2015-04-01 | 0.55 (+0.00%) | ||
| 0.2:1 Stock Split | 2013-09-19 | 4.07 (-5.50%) |
Show
Entries
China Biotech Services Holdings Ltd Frequently Asked Questions
What is China Biotech Services Holdings Ltd(HKSE:08037)'s stock price today?
The current price of HKSE:08037 is HK$0.64. The 52 week high of HKSE:08037 is HK$1.33 and 52 week low is HK$0.30.
When is next earnings date of China Biotech Services Holdings Ltd(HKSE:08037)?
The next earnings date of China Biotech Services Holdings Ltd(HKSE:08037) is .
Does China Biotech Services Holdings Ltd(HKSE:08037) pay dividends? If so, how much?
China Biotech Services Holdings Ltd(HKSE:08037) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on China Biotech Services Holdings Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers